Fifth Third Bancorp’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$706K Buy
31,694
+31,079
+5,053% +$743K ﹤0.01% 1842
2025
Q4
$16.4K Sell
615
-146
-19% -$3.49K ﹤0.01% 1967
2025
Q3
$16.2K Buy
761
+346
+83% +$8.18K ﹤0.01% 1970
2025
Q2
$8.95K Sell
415
-255
-38% -$4.74K ﹤0.01% 2050
2025
Q1
$11.1K Buy
+670
New +$12.2K ﹤0.01% 1961
2023
Q4
Sell
-443
Closed -$9.23K 2492
2023
Q3
$9.23K Buy
+443
New +$12K ﹤0.01% 1981
2023
Q1
Sell
-1,000
Closed -$15.9K 2755
2022
Q4
$15.9K Hold
1,000
﹤0.01% 1793
2022
Q3
$16K Hold
1,000
﹤0.01% 1770
2022
Q2
$14K Hold
1,000
﹤0.01% 1867
2022
Q1
$24K Hold
1,000
﹤0.01% 1738
2021
Q4
$23K Sell
1,000
-1,130
-53% -$22.7K ﹤0.01% 1805
2021
Q3
$35K Hold
2,130
﹤0.01% 1583
2021
Q2
$52K Hold
2,130
﹤0.01% 1435
2021
Q1
$55K Buy
+2,130
New +$93.8K ﹤0.01% 1383
2019
Q2
Sell
-3,800
Closed -$102K 2248
2019
Q1
$102K Hold
3,800
﹤0.01% 1055
2018
Q4
$61K Hold
3,800
﹤0.01% 1179
2018
Q3
$79K Hold
3,800
﹤0.01% 1164
2018
Q2
$58K Hold
3,800
﹤0.01% 1264
2018
Q1
$85K Sell
3,800
-900
-19% -$24.9K ﹤0.01% 1141
2017
Q4
$142K Hold
4,700
﹤0.01% 950
2017
Q3
$177K Hold
4,700
﹤0.01% 913
2017
Q2
$131K Hold
4,700
﹤0.01% 994
2017
Q1
$162K Sell
4,700
-2,345
-33% -$82.8K ﹤0.01% 945
2016
Q4
$203K Sell
7,045
-3,948
-36% -$104K ﹤0.01% 904
2016
Q3
$350K Buy
10,993
+1,001
+10% +$33.9K ﹤0.01% 786
2016
Q2
$324K Sell
9,992
-2,723
-21% -$91.1K ﹤0.01% 809
2016
Q1
$356K Buy
12,715
+4,223
+50% +$92.1K ﹤0.01% 786
2015
Q4
$303K Buy
8,492
+3,774
+80% +$133K ﹤0.01% 848
2015
Q3
$156K Buy
4,718
+18
+0.4% +$749 ﹤0.01% 1028
2015
Q2
$197K Sell
4,700
-82
-2% -$3.17K ﹤0.01% 1003
2015
Q1
$156K Sell
4,782
-4,367
-48% -$150K ﹤0.01% 1061
2014
Q4
$290K Sell
9,149
-259
-3% -$7.34K ﹤0.01% 867
2014
Q3
$233K Buy
9,408
+6,856
+269% +$160K ﹤0.01% 920
2014
Q2
$58K Sell
2,552
-282
-10% -$5.89K ﹤0.01% 1367
2014
Q1
$69K Buy
2,834
+1,234
+77% +$31.2K ﹤0.01% 1290
2013
Q4
$40K Buy
+1,600
New +$37.7K ﹤0.01% 1419

Other funds holding ACAD